Verition Fund Management
IRON icon

Verition Fund Management’s Disc Medicine IRON Stock Holding History

Verition Fund Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-63,535
Closed -$5.05M – 2921
2025
Q4 		$5.05M Buy
63,535
+57,402
+936% +$4.85M 0.02% 870
2025
Q3 		$405K Buy
+6,133
New +$365K ﹤0.01% 3139
2025
Q2 		– Sell
-4,279
Closed -$212K – 3748
2025
Q1 		$212K Buy
+4,279
New +$238K ﹤0.01% 3029
2024
Q4 		– Sell
-11,980
Closed -$589K – 3364
2024
Q3 		$589K Buy
+11,980
New +$562K ﹤0.01% 2226

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Verition Fund Management's IRON Position: Q1 2026 in Review

Verition Fund Management sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 63,535 shares — an estimated $5.05M sold.

Verition Fund Management first reported a position in IRON in Q3 2024 and held it in 4 quarters. The position peaked at $5.05M in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Verition Fund Management reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 63,535 Disc Medicine shares in Q1 2026, an estimated $5.05M.
  • Verition Fund Management first reported a position in Disc Medicine in Q3 2024 and held it in 4 quarters.
  • Verition Fund Management's Disc Medicine position peaked at $5.05M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.